The US Food and Drug Administration had inspected the subsidiary Strides Pharma Inc.’s facility at Chest Ridge, New York, US, from December 17, 2205 to December 23, 2025.
The US Food and Drug Administration had inspected the subsidiary Strides Pharma Inc.’s facility at Chest Ridge, New York, US, from December 17, 2205 to December 23, 2025.